BECN1 and neoplasm: In this study, we developed an injectable SF-platform (IMSFs-mediated MDT combined with TAT-Beclin1), a novel therapeutic strategy designed to induce a temporally controlled cascade of ferroptosis, autophagy, and immune activation for tumor therapy.